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Abstract We cloned two novel members of the CLC chloride 
channel family from rat and human brain. CIC-6 is a 97-kDa 
protein, and CIC-7 a 89-kDa protein roughly 45% identical with 
CIC-6. Together they define a new branch of this gene family. 
Both genes are very broadly expressed, e.g. in brain, testes, mus- 
cle and kidney. In mouse embryos, both genes are expressed as 
early as day 7. While the human gene for CIC-6 is located on 
human chromosome lp36 and shares this region with hCIC-Ka 
and hCIC-Kb, CIC-7 is on 16p13. CIC-6 has a highly conserved 
glycosylation site between transmembrane domains D8 and D9, 
while CIC-7 is the only known eukaryotic CIC protein which lacks 
this site. Hydropathy analysis indicates that domain D4 cannot 
serve as a transmembrane domain. Both CIC-6 and CIC-7 cannot 
be expressed as chloride channels in Xenopus oocytes, 
either singly or in combination. 
Key words: Chromosomal localization; Anion channel; Tissue 
distribution; Xenopus oocyte 
1. Introduction 
The expression cloning of the voltage-gated chloride channel 
C1C-0 from the electric organ of the marine ray Torpedo mar- 
morata [1] led to the subsequent discovery of a large gene family 
of related proteins [2], which even includes members from Sac- 
charomyces cerevisiae [3] and Escherichia coli [4]. In a single 
mammalian species, seven different C1C genes have been de- 
scribed so far [5-12]. These display differential tissue distribu- 
tion and perform diverse functions. Thus, C1C-1, the main 
skeletal muscle chloride channel [5], is important for stabilizing 
the plasma membrane voltage of muscle. Its mutational inacti- 
vation both in animal models [13] and in humans [14] leads to 
myotonia, an inherited muscle disease caused by an electrical 
hyperexcitability of the muscle membrane. C1C-2 is an ubiqui- 
tously expressed chloride channel [6] which can be activated by 
hypotonic swelling and may be important for cell volume regu- 
lation [15] and regulation of neuronal excitability [16]. CIC-5, 
the most recently discovered member of this gene family, is 
highly expressed in kidney, but to some degree also in other 
organs, such as lung and brain [11,12]. Mutations in this chlo- 
ride channel ead to X-linked kidney stone disease [11,17]. The 
function of other members of this gene family (CIC-Ka and 
CIC-Kb [7,8], C1C-3 [9,18] and C1C-4 [2,10]), however, is cur- 
rently obscure. This problem is compounded by the fact that 
functional expression as chloride channels, as reported by one 
group [7,9], could not be reproduced by other groups [2,8,18]. 
Thus, they should presently rather be classified as putative 
chloride channels. Site-directed mutagenesis has begun to shed 
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light on the structure-function relationship of the expressible 
channels [15,17,19,20]. 
In an attempt o learn more about this family of chloride 
channels, their functions and their possible role in disease, we 
have now cloned and analysed two novel mammalian C1C 
cDNAs. Starting from an established sequence tag (EST) from 
the genome project [21], we have cloned C1C-6. This putative 
channel was then used as the basis for a PCR-based strategy 
which led to the identification of C1C-7, which is only 45% 
identical with C1C-6. Both putative channels show a nearly 
ubiquitous tissue distribution, but cannot be expressed func- 
tionally as chloride channels in the Xenopus oocyte system. 
2. Materials and methods 
2.1. Cloning of ClC-6 and ClC-7 eDNAs 
hC1C-6 was cloned from a human frontal cerebral cortex cDNA 
library in AZAPII (Stratagene No. 936212) using three non-overlapping 
42-bp oligonucleotides complementary to the EST with the accession 
No. D28475 [21]. They were end-labeled with 32p and hybridized to the 
library at 42°C in 1 x SSC, 5 x Denhardt's and 0.1% SDS. Four inde- 
pendent cDNA clones hybridizing to all three probes were isolated and 
analysed. Two clones (HC11, 2525 bp; B2A, 4140 bp) covered the full 
coding region which was sequenced on both strands using an auto- 
mated DNA sequencer (ABI 373) or manual sequencing, when appro- 
priate. In the coding region overlapping with EST D28475, its sequence 
was fully confirmed. The sequence was deposited in the Genbank/ 
EMBL database, accession No. X83378. 
To clone rC1C-7, we designed several 'subfamily primer' pairs based 
on the principles outlined in section 3. The successful combination was 
directed against he C1C-6 amino-acid sequences EVKCYLNG and 
GKEGPMIH flanking domain D3. The degenerate primers repre- 
sented all possible codons and incorporated 5' EcoRI sites for sub- 
cloning. Polymerase chain reaction (PCR) was performed on about 100 
ng of rat brain cDNA using 60 cycles of 30 s at 94°C, 45 s at 53°C and 
45 s at 72°C. Amplification products of the right size (161 bp) were 
cloned and sequenced. About half were rCIC-6 fragments and the other 
class was different from, but homologous to, known C1C genes. This 
fragment was used to clone full-length C1C-7 from a rat brain cDNA 
library in 2ZAP (a gift from W. Meyerhof), aportion of which was then 
used to isolate a human C1C-7 cDNA (which lacks the 5' end) from the 
human cerebral cortex library. The sequences of these clones were 
deposited in the Genbank/EMBL database, accession No. Z67743 and 
Z67744. 
2.2. Chromosomal localization 
Genomic CIC-6 and C1C-7 clones were isolated from a human pla- 
centa library in AFIXII (Stratagene No. 946206) and their inserts were 
subcloned into pBluescript plasmid. Their identity was confirmed by 
partial sequencing using internal primers. Chromosomal localization 
by fluorescent in situ hybridization (FISH) (BIOS Laboratories, New 
Haven, CT) was performed by labeling the genomic lones with biotin 
dUTP and hybridizing to normal metaphase chromosomes derived 
from PHA stimulated peripheral blood lymphocytes, ubsequent incu- 
bation with fluoresceinated avidin and counterstaining with propidium 
iodide. This indicated that CIC-6 is located on chromosome lp36 and 
CIC-7 on 16p 13. The identity of the chromosomes was then confirmed 
by co-hybridizing the clones with respective chromosome-specific 
probes. 
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2.3. Northern blots 
Blots with 2 pg polyA ÷ RNA from several human tissues (Clontech) 
or whole mouse mbryos (embryonal days 7 17) were hybridized under 
high stringency conditions with riP-labeled cDNA inserts from hC1C-6 
or hCIC-7 (or rC1C-7 for the mouse blot) using standard conditions. 
Autoradiography was performed either with a phosphoimager (Fuji 
BAS1500) or films. 
2.4. Expression in Xenopus oocytes 
hClC-6 was assembled from two independent, overlapping clones by 
ligating the EcoRI/NarI fragment of the 5' clone HC11 and the NarI/ 
HindIII fragment of clone B2a into the EeoRIlHindIII sites of the 
expression vector pGemHE (a gift from A. Baumann). The initiator 
ATG with its endogenous Kozak consensus site is the first ATG 30-bp 
downstream of the polylinker, rCIC-7 has an NeoI site on its intitiator 
ATG which was used to clone it into the NcoI site of PTLN (Lorenz 
and Jentsch, in prep.). Both vectors place the start site for translation 
downstream of the Xenopus fl-globin 5' untranslated region [22]. Since 
our human CIC-7 clone lacks about 15 amino acids at the 5' end, we 
also constructed a chimeric rat/human C1C-7 in which the first 16 amino 
acids of rat C1C-7 were put before the first amino acid (aspartate) in
front of human C1C-7 using recombinant PCR. Using Sp6 RNA polym- 
erase, capped cRNA was prepared from these constructs after lineariza- 
tion. About 5 50 ng of cRNA was injected into Xenopus ooyctes pre- 
pared and handled as described [1]. After 2-3 days at 18°C, they were 
investigated by two-electrode voltage-clamping. 
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Fig. 1A. Sequence comparison of C1C-6, C1C-7 and C1C-2. Shown are the rat (prefix r) and human sequences (prefix h). For rat rCIC-7, only those 
amino acids differing from hC1C-7 are shown. Identical amino acids are indicated by dots. For hC1C-7, we still miss the 5' end. CIC-6 and CIC-7 
are approximately 45% identical and share about 21% identity with the ubiquitous volume-activated channel C1C-2 [6]. Residues identical between 
CIC-6 and C1C-7, or between all three proteins, are boxed. Putative transmembrane domains D1-DI2 are highlighted by solid lines, and the highly 
conserved cytoplasmic domain D13 is indicated by a shaded bar. N-linked glycosylation consensus sites predicted to be extracellular e indicated. 
Note that C1C-7 lacks N-linked glycosylation sites between D8 and D9. All other known eukaryotic C1C proteins have such sites at this position, 
which are known to be used in the CIC-K proteins [8] and CIC-0 [24]. 
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3.  Resu l t s  
Search of the Genbank/EMBL database using the TBlastN 
algorithm revealed a partial human cDNA sequence of 4815 bp 
(accession No. D28475) with significant homology to the C1C 
family of chloride channels. It represents a randomly picked 
cDNA clone from the human immature myeloid cell line KG-1 
[21]. The protein sequence predicted by this partial clone begins 
at putative transmembrane span D5 and extends beyond the 
stop codon. Thus, we predicted that it lacks about 500 bp of 
5' sequence, including the coding region for the first 4 trans- 
membrane domains. To conform with the nomenclature for the 
CIC family [2], we named this protein hCIC-6 (prefix h for 
human). 
Using specific oligonucleotides we isolated 5 independent 
C1C-6 clones from a human brain cDNA library. Two overlap- 
ping clones covered the entire coding region. The intiator 
methionine was assigned to the first ATG in frame. Its sur- 
roundings conform to the consensus equence of eukaryotic 
initiation of translation [23] and is preceded by a stop codon 
in frame. Its coding region predicts a 869 amino-acid protein 
with a molecular weight of 97 kDa (Fig. 1). Significant homol- 
ogy to other C1C proteins is spread over most of the protein, 
but is higher in putative transmembrane domains and neigh- 
bouring regions. In the central portion encompassing the trans- 
membrane regions, C1C-6 is only roughly 29% identical with the 
CLC-1 
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CLC-6 
CLC-7 
Fig. lB. Dendrogram graphically showing the similarities between 
mammalian CIC proteins. Note that C1C-6 and CIC-7 form a distinct 
subbranch of the family, which is most closely related to the C1C-3, 
C1C-4 and C1C-5 group. This plot has been generated using the Pileup 
program of the GCG software package. 
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Fig. 2. Hydropathy analysis of C1C-6, C1C-7 and, for comparison, 
C1C-2. The Kyte-Doolittle scale was used with a window size of 19 
residues. Note that the hydrophobic peak leading to the prediction of 
a putative transmembrane domain D4 is present in C1C-2, but is absent 
in C1C-6 and C1C-7. The weakly hydrophobic, but conserved omain 
D13 is now known to be cytoplasmic [15]. C1C-7 is shorter than C1C-6 
primarily because of a shorter stretch between D12 and D13. 
C1C-3, C1C-4 and C1C-5 branch and even less so to C1C-1, 
C1C-2 and CLC-K (~23%). Thus, it may represent the first mem- 
ber of a new subfamily of C1C proteins. 
We pursued this hypothesis by designing 'subfamily' primers 
for RT-PCR cloning experiments. We first identified regions 
which are highly conserved within a given branch of the C1C 
family, but show significant divergence between branches. We 
designed egenerate oligonucleotide primers which allowed for 
all possible triplets encoding the amino acids found in C1C-6 
in these specific regions. These primers will not recognize mem- 
bers of the C1C-1 and C1C-3 branches, but should amplify 
C1C-6 and hopefully other members of a new branch defined 
by C1C-6. Using several primer combinations based on this 
novel principle, we performed RT-PCR amplifications on rat 
brain cDNA. Indeed, we cloned a fragment encoding a novel 
C1C protein. It was used to isolate a full-length clone from a 
rat brain cDNA library. In addition, we isolated ahuman C1C-7 
cDNA which, however, still lacks coding sequence for about 
15 amino acids at the 5' end. Both clones were fully sequenced 
(Fig. 1A) and are 96% identical at the protein level, rC1C-7 is 
predicted to be a 89-kDa protein having 803 amino acids. 
Comparison with other C1C proteins indicates that C1C-6 
and C1C-7 (which share about 45% identity) belong to a com- 
mon, new branch of the C1C family (Fig. 1B). Compared with 
C1C-6, C1C-7 is smaller by more than 60 amino acids because 
of a shorter cytoplasmic stretch between D12 and D13. This 
stretch is poorly conserved between different C1C genes and 
differs in length between other C1C proteins as well. 
C1C-6 has two consensus ites for N-linked glycosylation 
between putative transmembrane domains D8 and D9. In this 
extracellular loop, glycosylation sites are present in all pub- 
lished eukaryotic C1C proteins, including the yeast homologue 
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Fig. 3. Tissue distribution of C1C-6 and C1C-7 and their expression 
during embryonic development. Northern blots with 2/Jg polyA ÷ RNA 
from several human tissues were probed with a human C1C-6 (A) or a 
human C1C-7 cDNA (B). Expression during mouse development was 
studied by analysing hybridization to2/Jg each of polyA ÷ RNAs from 
whole mouse embryos at days 7, 11, 15 and 17. C1C-6 message (C) 
increases slightly during the first 2 weeks, while C1C-7 (D) rather de- 
creases. The blots were probed with human C1C-6 and rat C1C-7, 
respectively. Blots in A and B and in C and D are identical, respectively, 
and were reprobed after stripping. 
scC1C-a [3]. With C1C-K1 and C1C-K2, site-directed mutagene- 
sis indicated that these sites are used [8] and biochemical nal- 
ysis of the native C1C-0 Torpedo channel came to the same 
conclusion [24]. C1C-7 is the first C1C protein lacking such a 
glycosylation site. There is no consensus equence in other 
predicted extracellular loops which could serve as a substitute. 
There are still other features of C1C-7 which are unique. In 
contrast o all other C1C proteins, including those from yeast 
and bacteria, it does not have a glutamic acid at position 208, 
but glutamine, and also lacks a proline at position 508 (replaced 
by serine). It is this highly conserved proline, which, when 
mutated to leucine in the muscle channel CIC-1, causes 
Thomsen's disease (autosomal dominant myotonia) in Dr. 
Thomsen's own family [19]. 
Hydropathy analysis of C1C-6 and C1C-7 reveals roughly the 
same pattern as for other members of this gene family, e.g. 
C1C-2 (Fig. 2). In contrast o C1C-2, however, they lack the 
hydrophobic peak which suggested that D4 spans the mem- 
brane [1]. The present data, thus, support our more recent 
model [2,20]. This changed topology model is also consistent 
with an extracellular localization of the loop between domains 
D8 and D9, which is necessary to explain its glycosylation 
[8,24]. 
Northern analysis uggests that both genes are broadly ex- 
pressed. The C1C-6 probe recognizes mainly a ~6-kb message in 
human tissues (Fig. 3A), which seems lightly smaller in mouse 
(Fig. 3C). In both species, there is also a larger minority tran- 
script which may be due to alternative polyadenylation. Expres- 
sion is most prominent in testis, ovary, small intestine, brain 
and skeletal muscle, but faint bands are detectable in every 
tissue examined. CIC-7 recognizes a ~4.2-kb message which is 
also broadly expressed, including again testis, brain and skele- 
tal muscle (Fig. 3B). As compared with C1C-6, expression ist 
stronger in pancreas, kidney, liver and lung. During develop- 
ment in mice, CIC-6 and C1C-7 transcripts are present early on 
(Fig. 3C,D). They could be detected in whole embryos at days 
7, 11, 15 and 17. While CIC-6 expression increases during the 
first 2 weeks, C1C-7 mRNA levels decrease. 
Since mutations in C1C-1 and C1C-5 cause inherited isease 
in humans [14,17,19], we localized C1C-6 and C1C-7 in the 
human genome to see whether they could be candidate genes 
for human disease. FISH to human metaphase chromosomes 
localized CIC-6 on chromosome lp36, while C1C-7 is encoded 
on 16p13. 
C1C-6 and C1C-7 belong to a gene family which includes 
several well-characterized chloride channels [1,5,6]. We, there- 
fore, tried to express them functionally in Xenopus oocytes. We 
cloned the cDNAs into the highly efficient expression vectors 
PTLN and pGEMHE, transcribed cRNA in vitro and injected 
it into Xenopus oocytes. After 2-3 days, they were examined by 
two-electrode voltage clamp. However, similar to our previous 
experience with the C1C-K channels [8] and with C1C-3 and 
CIC-4 [2], we were unable to detect novel chloride currents with 
hC1C-6, rC1C-7 and also with hC1C-7 to which we had added 
the first 16 amino acids from the rat clone. Injecting large 
amounts of cDNA, in contrast, yielded anion currents with an 
iodide > chloride conductivity sequence which activated slowly 
upon strong hyperpolarization (i  excess o f -  100 mV) (data not 
shown). However, similar currents are endogenous to Xenopus 
oocytes [25] and can also be provoked by overexpression of
phospholemman [26], Mat-8 [27], minK (also named IsK [28]) 
[29] and mutants of C1C-1 which are closed in that voltage- 
range [19]. Thus, it seems that these currents are just an artifact 
of overexpressing membrane proteins in Xenopus oocytes [30]. 
Since C1C-1 is functional as a (homo)multimer [19], we also 
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explored the possibility whether CIC-6 or C1C-7 together can 
form functional heterooligomers, but again with negative re- 
sults. Also co-expression with several other members of this 
gene family (C1C-K, C1C-3 and C1C-4) as well as attempts to 
activate channels by second messengers proved to be unsuc- 
cessful in preliminary experiments. 
4. Discussion 
With CIC-6 and C1C-7, we have identified and characterized 
two new members of the expanding C1C superfamily of chloride 
channels. These two genes define a new subbranch which is 
most closely related to C1C-3, C1C-4 and C1C-5, with which 
they share about 30% identity. C1C-6 and C1C-7 are only 45% 
identical with each other and, thus, are less related than e.g. 
C1C-1 is to C1C-2. 
While hydropathy analysis of the C1C-0, C1C-1 and C1C-2 
chloride channels previously suggested a putative transmem- 
brane domain D4 [1,5], the corresponding regions in C1C-6 and 
C1C-7 are clearly not hydrophobic enough to support that 
conclusion. Elimination of D4 as a transmembrane domain 
supports a revision of the original topology model [1] for C1C 
chloride channels, which puts the loop between D8 and D9 
outside the cell [20]. This loop is known to be glycosylated both 
in the CIC-K proteins [8] and in C1C-0 [24]. Glycosylation 
consensus ites are present in this same loop in all previously 
known eukaryotic C1C proteins, including yeast, but surpris- 
ingly not in C1C-7. When compared with C1C-6, this is due to 
two small deletions, which can be found both in rat and human 
CIC-7. 
hC1C-6 is located on human chromosome lp36, while the 
hC1C-7 locus is on 16p13. No diseases have been mapped to 
these loci for which C1C-6 or CIC-7 would be obvious candidate 
genes. Interestingly, the loci for the human kidney-specific 
channels hC1C-Ka and hC1C-Kb are also on lp36 (Grimm, 
Kieferle and Jentsch, unpubl, data). Thus, there is a cluster of 
CIC genes in this chromosomal region. For C1C-Ka and CIC- 
Kb, this is not surprising, as they are 90% identical and may 
have arisen by a comparatively recent gene duplication. How- 
ever, C1C-6 belongs to a distant branch of this family and its 
closest known cousin is on chromosome 16. The other C1C 
genes are located on different human chromosomes: C1C-1 on 
7p35 [14], C1C-2 on 3q26-3qter [31], C1C-3 on chromsome 4 
[18], C1C-4 on Xp22.3 [10] and C1C-5 on Xpl 1.22 [11]. 
As with other members of this gene family (C1C-K, C1C-3 
and CIC-4) [8,2,18], we were unable to express C1C-6 and C1C-7 
functionally as chloride channels in Xenopus oocytes. Since 
C1C-1 functions as a homomultimer [19], we speculated that 
different C1C proteins may also combine to form heteromulti- 
meric channels. We, therefore, examined C1C-6/C1C-7 co-injec- 
tions and also tried co-expression with other C1C proteins. 
However, none of these procedures elicited any novel currents. 
There are several possible ways to explain why C1C-6 and 
C1C-7 (and other members of the gene family) cannot be func- 
tionally expressed as chloride channels. We could miss another 
subunit necessary for its functional expression, either belonging 
to the same gene family, or representing a different 'fl-subunit' 
as for other channels [32]. Second, the expression system (Xen- 
opus oocytes) may not be appropriate. Third, C1C-6 and C1C-7 
may be channels which are regulated in a complicated way 
which we have not yet understood. In fact, many patch-clamp 
studies have revealed chloride channels which can only be ob- 
served after patch-excision [33]. Fourth, these channels may 
reside in intracellular organelles, which are known to possess 
chloride channels as well [34-36]. The iron-repressible p tite 
phenotype of yeast mutants lacking a C1C homologue (which 
is structurally close to the C1C-3 to C1C-7 branch) may point 
into that direction [3]. This question should be addressed by 
immunofluorescence once good antibodies are available. For 
C1C-K proteins, however, which cannot be expressed as chlo- 
ride channels in our hands [2,8] (but see [7,37]), immunofluores- 
cence has shown its presence in the plasma membrane [37]. It 
is also interesting to note that C1C-5 reproducibly yields large 
chloride currents in oocytes [12,17], but that the highly related 
(> 85% identity) C1C-3 and C1C-4 proteins do not elicit chloride 
currents [2,18] (but see [9]). It would seem unlikely, but not 
impossible, that these highly related (> 85% identity) proteins 
would be sorted to different compartments. Finally, C1C-6 and 
CIC-7 may not be chloride channels, but perform other func- 
tions. Although seemingly far-fetched, there is at least one 
precedent: CFTR, the cystic fibrosis transmembrane conduct- 
ance regulator, functions as a chloride channel even though it 
belongs to a superfamily of transport ATPases [38]. 
Similar to C1C-2 [6], both C1C-6 and C1C-7 are quite ubiqui- 
tously expressed, although they differ in detail. Both genes are 
also expressed in rather early stages of embryonic development 
(day 7 for mouse embryos). These observations may suggest 
house-keeping functions for both proteins. When expressed in 
Xenopus oocytes, C1C-2 can be activated by hypotonic swelling 
[15], but this protocol did not elicit currents in oocytes express- 
ing C1C-6 or CIC-7. The very broad expression of C1C-6 and 
C1C-7 implies that there are many tissues which express everal 
different C1C genes at the same time. For instance, skeletal 
muscle expresses at least C1C-1, C1C-2, CIC-3, C1C-4, C1C-6 
and C1C-7. The function of C1C-1 in stabilizing the membrane 
voltage is well-understood, especially because mutations in this 
gene lead to myotonia [13,14]. The function of C1C-2 appears 
unclear in that particular tissue, because the swelling activation 
of a new chloride conductance on top of the high conductance 
mediated by CIC-1 will not contribute significantly to volume 
regulation. The functions of the remaining C1C proteins, in- 
cluding C1C-6 and C1C-7, is still obscure in this and other 
tissues. Their elucidation is a challenging problem for the fu- 
ture. 
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